Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Kenneth Grossmann

3PUBLICATIONS

48CO-AUTHORS

Predictive and prognostic markersInnate immunityHaematological tumours

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Jun 23, 2026

Addressing Biases in Analysis of Time of Infusion: NCI/SWOG Trial S1404 Among Participants With High-Risk Resectable Melanoma Who Received Adjuvant Anti-PD-1 Therapy.

|Apr 08, 2024

Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity.

Isabella C Glitza, Yongwoo David Seo, Christine N Spencer

|Nov 12, 2021

Adjuvant Pembrolizumab versus IFNα2b or Ipilimumab in Resected High-Risk Melanoma.

Kenneth F Grossmann, Megan Othus, Sapna P Patel

Pageof 1

Frequent Collaborators

2 joint publications

Sapna P Patel

2 joint publications

Vernon K Sondak

2 joint publications

Kari Kendra

2 joint publications

Elad Sharon

2 joint publications

John M Kirkwood

2 joint publications

Antoni Ribas

1 joint publications

Ahmad A Tarhini

1 joint publications

Pauline Funchain

1 joint publications

Bartosz Chmielowski

1 joint publications

Nageatte Ibrahim

Frequent Collaborators

2 joint publications

Sapna P Patel

2 joint publications

Vernon K Sondak

2 joint publications

Kari Kendra

2 joint publications

Elad Sharon